Wellington Partners

Dr Ulrich Granzer has joined Wellington Partners as a new venture partner. With more than ten years of management experience, including positions at Glaxo Wellcome and BASF, Ulrich Granzer set up his own company in 2002. He now works as an independent consultant to both pharmaceutical companies as well as biotech providers in connection with drug development and regulatory affairs. The new Venture Partner has already been involved with Wellington's portfolio company, immatics, for more than a year as a member of its advisory council and as a co-investor. Working in close coordination with the regulatory authorities, his involvement enabled preclinical testing to be shortened by at least three to six months as opposed to the original planning. Since joining Glaxo Wellcome in 1989, Granzer had been able to gather a wealth of experience in regulatory affairs. At Glaxo Wellcome, he last served as a member of the global regulatory board, operating out of Hamburg and London. He then worked at Germany's two leading pharmaceutical houses, Bayer and BASF Pharma, where he held global responsibility for regulatory affairs.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• DACH